Home Cart 0 Sign in  

[ CAS No. 129938-20-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 129938-20-1
Chemical Structure| 129938-20-1
Structure of 129938-20-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 129938-20-1 ]

Related Doc. of [ 129938-20-1 ]

Alternatived Products of [ 129938-20-1 ]

Product Details of [ 129938-20-1 ]

CAS No. :129938-20-1 MDL No. :MFCD08272809
Formula : C21H24ClNO Boiling Point : -
Linear Structure Formula :- InChI Key :IHWDIQRWYNMKFM-BDQAORGHSA-N
M.W : 341.87 Pubchem ID :71352
Synonyms :
LY-210448 hydrochloride;Dapoxetine (hydrochloride);​(S)-(+)-Dapoxetine;LY-210448;Dapoxetine hydrochloride

Calculated chemistry of [ 129938-20-1 ]

Physicochemical Properties

Num. heavy atoms : 24
Num. arom. heavy atoms : 16
Fraction Csp3 : 0.24
Num. rotatable bonds : 6
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 104.02
TPSA : 12.47 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -3.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 6.37
Log Po/w (WLOGP) : 5.39
Log Po/w (MLOGP) : 4.37
Log Po/w (SILICOS-IT) : 4.55
Consensus Log Po/w : 4.14

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -6.07
Solubility : 0.000291 mg/ml ; 0.000000851 mol/l
Class : Poorly soluble
Log S (Ali) : -6.42
Solubility : 0.000129 mg/ml ; 0.000000377 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -7.29
Solubility : 0.0000177 mg/ml ; 0.0000000518 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.55

Safety of [ 129938-20-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 129938-20-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 129938-20-1 ]

[ 129938-20-1 ] Synthesis Path-Downstream   1~16

  • 1
  • [ 119356-77-3 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
96% With hydrogenchloride In Isopropyl acetate Cooling with ice; 6 Example 6 10g of dapoxetine was dissolved in 25mL anhydrous isopropyl acetate in an ice-salt bath while stirring with dry hydrogen chloride gas. After 30 minutes of reaction, cold 20mL solution of tert-butyl ether was used in crystallization. The crystals were collected by filtration and dried to obtained 10.8g dapoxetine hydrochloride polymorphs. Its yield was 96% with a purity of 99.12% and chiral purity of 99.33%,
95.6% With hydrogenchloride In ethyl acetate at 20℃; Preparation of dapoxetine hydrochloride Compound d (6.1 g, 20 mmol) was dissolved in 100 mL of ethyl acetate.Bubble hydrogen chloride gas at room temperature until saturation, filter with suction, wash the solid three times with ethyl acetate,After drying at room temperature, 6.5 g of the final product was obtained. Yield: 95.6%, purity: 98.91%.
93% With hydrogenchloride In di-isopropyl ether; lithium hydroxide monohydrate 4 Example 4 Preparation of dapoxetine hydrochloride Compound I (4.8g, 0.016) was dissolved in 48ml of isopropyl ether,isopropyl ether was slowly added dropwise a solution of hydrogen chloride untilno solid precipitate was filtered, dried under vacuum to give dapoxetinehydrochloride white solid 5.0g ( ee of> 99%, yield 93.0%).
87.53% With hydrogenchloride In ethyl acetate; isopropanol at 0 - 20℃; 26 Example-26: Preparation of Dapoxetine hydrochloride; Taken 50gr. of dapoxetine, 250ml. of ethyl acetate at ambient temperature and heated to 45-50°C.Added 5gr. of special carbon and stirred for lOmin. at 45-50°C and the reaction mass was filtered through carbon bed. The carbon bed was washed with 50ml. of hot ethylacetate.The ethyl acetate layer was cooled to ambient temperature. Then added 50ml. of 18% Isopropyl alcohol hydrochloric acid mixture drop-wise within 45-60min.Then the reaction mass was stirred for 30min. at ambient temperature and cooled to 0-5°C.The reaction mass was filtered and the cake was washed with 50ml. of chilled ethyl acetate and dried at 90-95°C for 4hrs. to furnish 49gr. of the title compound.Wt: 49 g. (%Yield: 87.53%); Purity by HPLC: 99.98%; Chiral purity: 99.98% and R-isomer: 0.012% ; SOR: (+) 130.72° (C=l% in CH3OH) ; Assay: 100.51%; M.P: 180-182°C.
86% With hydrogenchloride In ethyl acetate for 1h; Cooling with ice; 8 The above oil (103 g) was dissolved in ethyl acetate (400 ml)A dry hydrogen chloride gas was introduced into the reaction solution under an ice bath,Stirring lh,To the reaction solution p Η = 1.0 stop ventilation, stirring at room temperature lh.Filtration to obtain a white solid, that was 99.1g dapoxetine hydrochloride, the yield of 86%, the product of mp 178-180 ° C, [a] 23D = +129 ~ 130, c = l, Me0H.
85% With hydrogenchloride In 2-methoxy-2-methylpropane; lithium hydroxide monohydrate 3 Example 3 Compound 6 (1.0 g, 0.015 mol) was dissolved in 10 ml anhydrous methyl tert-butyl ether,A solution of hydrogen chloride in methyl tert-butyl ether was added dropwise to the solution until no more white solids were produced.1.10 g (yield 97.7%) of pale white powder was filtered.The resulting compound was used as a 22-fold amount of isopropanol:Recrystallization from n-hexane (1:1) gave 0.85 g of white powder 1 (yield 85%).[α]25 D = +130.9° (c = 1%, methanol), mp 179.1-180.2°C.
85% With hydrogenchloride In Isopropyl acetate Large scale; 2.4; 2.5 Step 4: Dimethylation Dichloromethane (25.0 kg) was added sequentially to a 50-L reactor.The intermediate II obtained in the above step (2.50 kg 9.98 mol)Stir and maintain the temperature at 1025°C.Add 5% sodium hydroxide solution dropwise, 0.5 ~ 1.0h drop is completed,After stirring until the solution is completely clarified, the solution is separated and the dichloromethane layer is separated.Dichloromethane (5.0 kg) was added to the aqueous layer, stirred, and the solution was separated.The methylene chloride phases were combined, washed with purified water (5.0 kg), and partitioned to give a dichloromethane solution.The methylene chloride solution was transferred to a 50 L reactor and methanol (0.38 kg, 12.0 mol) was added.Formaldehyde aqueous solution (9.70kg), open nitrogen protection, at 20 ~ 30 °C,Sodium triacetoxyborohydride (12.0 kg, 56.50 mol) was added slowly and the addition was completed between 2.0 and 3.0 h.After the addition is completed, the reaction is carried out at 20 to 30°C for 1.5 to 3.0 hours. Add purified water (30.0kg)Keep the temperature at 5-20°C, add 20% sodium hydroxide solution to the system.When the pH of the system is between 9.0 and 11.0, stop dropping and stir for 20-30 minutes.The reaction mixture was separated, and the dichloromethane layer was separated. Dichloromethane (10.0 kg) was added to the aqueous layer and stirred.Stationary liquid. Combine the methylene chloride layer and transfer it to a 100-liter reactor.Add purified water (30.0 kg) and stir. The methylene chloride layer was separated and repeatedly washed with purified water (150.0 kg). The dichloromethane layer was combined.Anhydrous magnesium sulfate (2.0 kg) was added to the dichloromethane layer and dried for 3.0-5.0 h. filter,The solid was washed twice with methylene chloride and 2.0 kg each time. The diamino compound in dichloromethane was collected. The solvent was concentrated under reduced pressure to give the crude free base.Soluble in 10kg isopropyl acetate, pass hydrogen chloride gas (1.6~2.0kg),After the feed was stopped, the system gradually precipitated solids and stirred for 3.0-4.0 h. filter,Dapoxicillin hydrochloride 2.8 kg was obtained in a yield of 85%. Step 5: Refinement of the crude productTo a 20-L reactor, isopropanol (15.0 kg) was added in sequence.Dapoxetine hydrochloride crude product 2.8kg, stirring, heated to 60 ~ 70 °C, after all the system dissolved and clarified,The hot filter was used to remove mechanical impurities, and the temperature was controlled at 35-45°C and stirred for 1.0-2.0h.Then cool down to 20 ~ 30 °C, stirring and devitrification 3.0 ~ 4.0h. 2.38 kg of pure product was obtained by filtration, yield 85%.
78.5% With hydrogenchloride In methanol; lithium hydroxide monohydrate at 0 - 30℃; Large scale; 1.S4; 3 Step S4, salt formation reaction. At 0~30°C, 14.4kg of methanol was added to the 100L reaction kettle, 9.6kg of dapoxetine prepared in step S3 was added, stirred, 4.8kg of hydrochloric acid gas was introduced, and the detected pH was about 1.0, and the solution was clear. Cool down to 0±5°C, add 120kg of methyl tert-butyl ether dropwise, finish adding in 2h, keep stirring at 0±5°C for 2-4h after dripping, and centrifuge to obtain dapoxetine hydrochloride as a white solid. It was placed in a vacuum drying oven, and the temperature was controlled at 45-55° C., and dried to obtain 8.42 kg of white solids, and the calculated yield was 78.5%.The obtained dapoxetine hydrochloride white solid was detected and analyzed by HPLC.
40% With hydrogenchloride In lithium hydroxide monohydrate for 2h; 1 In a 2 L three-mouth bottle by adding 500 ml tetrahydrofuran, lowering the temperature to 0 °C, adding 23.0 g (0.606 µM) NaBH4, Added under mixing 50 g (S)-3 - amino -3 - phenyl propionic acid dap - 1 (303 µM). The 77 g iodine (0.303 µM) dissolved in 250 ml of tetrahydrofuran, is added to the reaction solution under stirring in the drop. Then completing, heating reflux for 20 hours, stopping the reaction, cooling, dropping 50 ml methanol quenching reaction. The organic solvent and steaming and remove, dropping 20% NaOH solution, to PH is 8 - 10, the stirring 2 h. Ethyl acetate is divided into 3 time extraction, the combined organic phase. The addition of about 10% formic acid solution stirring, liquid. In the aqueous phase by adding 70 ml 85% formic acid and 140 ml 37% formaldehyde, 90 °C lower reaction 8 hours. The cooling, for 20% NaOH to adjust the PH to 8 - 10, ethyl acetate extraction three times, the combined organic phase, turns on lathe does (S)-3 - dimethyl amino -3 - phenyl propanol dap - 3 crude product. The dap - 3 crude and 37.0g1 - [...] adding 2 L three-opening in the bottle, at room temperature by adding 380 mLN, N - dimethyl formamide and 47.3 g tert-butanolate, the temperature is raised to 70 °C stirring 5 h. The reaction liquid to room temperature, hexane and water added, stirring 15 minutes, standing liquid. The upper layer is cetane collected, washed with water once. Hexane phase and steaming and to remove the solvent, adding tetrahydrofuran is dissolved. Stirring next adds by drops 26.2 ml concentrated hydrochloric acid. Reaction 2 hours, steaming and remove the tetrahydrofuran and water, to the solvent-free steam, adding isopropanol, steaming and to the solvent-free steam. In the resultant product added to isopropanol, heating under stirring to make it dissolve completely. Stop heating, dropping ethyl acetate, during the dropping out of the crystal. After dropping cooling to room temperature, continuing to stir overnight, filtered, the filter cake is washed with ethyl acetate, and a ground line, N2 dry, product west reaches anchors the sandbank hydrochloride 41 g, yield 40%.
With hydrogenchloride In ethyl acetate at 0 - 5℃; for 1h; 7 Example-7 Preparation of (+)-Dapoxetine Hydrochloride:The solution of 60 g of Dapoxetine base is prepared in 480 mL of ethyl acetate at 25° to 350C and is stirred for 15 minutes. The reaction is filtered through fine filter hyflosupercel bed at 250C t0 35°C and the bed is washed with 2 x 60 mL of ethyl acetate. The reaction mixture is taken into the flask and cooled to 00C to 50C. The HCl gas is purged at O0C to 5°C till the pH is acidic between 1- 2. The solid material is precipitated. The purging is stopped and the reaction mixture was stirred for 1 hour at O0C to' 50C. The product is filtered at 0° to 50C and washed with 2 x 60 mL of ethyl acetate (chilled). Purification: The solution of 125.6 g of (+)-Dapoxetine Hydrochloride is prepared in 377 mL of fine filtered isopropyl alcohol at 250C to 35°C. The reaction mixture is heated at reflux temperature to obtain the clear solution. The reaction mixture is maintained at reflux temperature for 15 minutes. The reaction mixture is cooled down to 25°C to 350C within 1 hour. The product starts precipitating at 450C to 55°C. The reaction mixture is stirred at 250C to 350C for 1 hour. The reaction mass is further cooled to 1O0C to 150C and was allowed to stirred at 1O0C to 150C. The reaction mixture is washed with fine filtered isopropyl alcohol (2 x 62.5 mL) and the product is dried at 5O0C to 550C. Chiral purity = (-) Dapoxetine : Below Detection Limit MD25 [C = 1% methanol] = + 131.7° M.P. : 18O0C-1840C.
10 g With hydrogenchloride In ethyl acetate; isopropanol at 25 - 30℃; for 2h; 6 ExampIe-6 The solid, (5^-(+)-N,N-Dimethyl-3-(Naphthalen-l-yloxy)-l-phenylpropan-l -amine Tartrate (12.0 g) is added into a mixture of dichloromethane (75ml) and water (75 ml). The organic layer separated after adjusting pH to 8-10. The organic layer is distilled completely to dryness to obtain a thick mass of solid. [a] D 25 (C=l, MeOH) = (+ ) 104° HPLC; Chiral (S-Isomer; 95%; R-Isomer-5%) To the above thick mass IPA-HCl (3 ml) is added in presence of ethyl acetate (30 ml). It is stirred for 2 hr at 25-30°C. The solid is filtered at 0-5°C.Yield is 10 gm. [a] D 25 (C=l, MeOH) = (+ ) 128° HPLC Chiral (S-Isomer 99.80, R-Isomer 0.08) HPLC Purity; 99.81% MR; 182-183°C
With hydrogenchloride In propan-2-one 4 A method for the synthesis of dapoxetine hydrochloride The present embodiment relates to a process for the preparation of dapoxetine hydrochloride, which comprises the steps of:(1) Preparation of S-dapoxetine according to the method described in Example 1;(2) A solution of (S) -N, N-dimethyl-1-phenyl-3- (naphthyl-1-oxo)(3.1 g, 0.01 mol) was dissolved in anhydrous acetone (20 mL)Ice bath slowly drip concentrated hydrochloric acid (0.45mL) to no white precipitate, filter, recovery of mother liquor, cake drying,The solid was recrystallized from isopropanol to give 2.9 g of dapoxetine hydrochloride (HPLC: 99.85%, . : 99.91%).
With hydrogenchloride In ethyl acetate at -5 - 20℃; 6; 7 Step 7: Preparation of finished product of dapoxetine hydrochloride 4g,24ml of ethyl acetate was added into a three-necked flask and dissolved with stirring at room temperature. The temperature was controlled to -5 DEG C to 0 DEG C and hydrogen chloride gas was introduced into the solution to adjust the pH of the solution to 2,The temperature was controlled at 0-5 ° C, and the mixture was filtered with suction after stirring for 1 hour. The filter cake was washed with ethyl acetate and dried at 40 ° C to obtain 4.27 g of crude dapoxetine hydrochloride.Yield 95%;_the crude product dapoxetine hydrochloride 4g,Isopropanol 20ml added to the three-necked flask, heated to reflux, clear,Slowly cooled to -5 ~ -10 stirring crystallization 1h after filtration,The filter cake was washed with a small amount of ethyl acetate and dried under reduced pressure at 40 ° C.Dapoxetine hydrochloride product 3.79g, 94.8% yield.
324 g With hydrogenchloride In lithium hydroxide monohydrate; ethyl acetate at 0 - 20℃; 1.3 Step 3: 480 g of (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy) amphetamine was dissolved in 1.5 L of ethyl acetate.After cooling to 0-5 ° C, dry hydrogen chloride gas was introduced into the solution until the pH of the solution was 1-2, and the mixture was stirred at room temperature for 4-5 h. Filtration gave a white solid,Dry at 45-50 ° C for 20-24 h,(S)-N,N-Dimethyl-(α)-[2-(1-naphthalenyloxy)ethyl]benzylamine hydrochloride 324 g was obtained.

Reference: [1]Current Patent Assignee: SUZHOU UUGENE BIOPHARMA - CN103664659, 2016, B Location in patent: Paragraph 0049; 0050
[2]Current Patent Assignee: YANGTZE RIVER PHARMACEUTICAL GROUP CO LTD - CN113801027, 2021, A Location in patent: Paragraph 0004; 0013-0014
[3]Current Patent Assignee: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. - CN103373931, 2016, B Location in patent: Paragraph 0100-0103
[4]Current Patent Assignee: SYMED LABS LIMITED - WO2011/161690, 2011, A1 Location in patent: Page/Page column 29
[5]Current Patent Assignee: SHANDONG ACAD OF MEDICAL SCIENCES - CN105732309, 2016, A Location in patent: Paragraph 0037; 0055
[6]Current Patent Assignee: LIAOCHENG UNIVERSITY - CN106748825, 2017, A Location in patent: Paragraph 0045
[7]Current Patent Assignee: HYGEIA CHENGDU PHARMACEUTICAL TECHNIQUE - CN107473977, 2017, A Location in patent: Paragraph 0034; 0037; 0038; 0039; 0040; 0041; 0042; 0043
[8]Current Patent Assignee: HUNAN JIUDIAN PHARMACEUTICAL; HUNAN JIUDIAN HONGYANG PHARMACY - CN113880721, 2022, A Location in patent: Paragraph 0040; 0047-0049; 0051; 0057-0058; 0061-0063
[9]Current Patent Assignee: GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. - CN107935868, 2018, A Location in patent: Paragraph 0045-0054
[10]Current Patent Assignee: ZYDUS LIFESCIENCES LTD - WO2008/35358, 2008, A2 Location in patent: Page/Page column 8; 13
[11]Current Patent Assignee: R L FINE CHEM - WO2014/24205, 2014, A1 Location in patent: Page/Page column 11
[12]Current Patent Assignee: HUNAN UNIVERSITY OF CHINESE MEDICINE - CN104610076, 2016, B Location in patent: Paragraph 0088-0091
[13]Current Patent Assignee: ANHUI JINNAN MEDICAL TECH - CN106748817, 2017, A Location in patent: Paragraph 0052; 0053
[14]Current Patent Assignee: TSINGHUA TONGFANG CO., LTD - CN109503397, 2019, A Location in patent: Paragraph 0039; 0049
  • 2
  • [ 321-38-0 ]
  • [ 82769-75-3 ]
  • Dapoxetine hydrochloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
97.5% 1.58 kg (8.8 mol) of (S) -<strong>[82769-75-3]3-dimethylamino-3-phenylpropanol</strong> obtained in the above was dissolved in 10 L of anhydrous N, N-dimethylacetamide under nitrogen, % Of sodium hydride 1.05 g (26.4 mol), heated to 65 C for 1.5 h, 1.54 kg (10.3 mol) of 1-fluoronaphthalene was added and the temperature of the reaction was raised to 100 C for 7 h. After the reaction was complete, Bath to join the 50L ice water, keep heating for 4h, filter, get the intermediate 3 crude.Recrystallization from 8.5 L of 50% ethanol gave 2.48 kg of intermediate 3, the free base as a white powder solid with a yield of 92.21%, a purity of 99.11% and a chiral purity of 99.79%. N, N-dimethylacetamide recovery cycle. Weigh 2.4 g of the free base prepared as described above was dissolved with 24 L of ethyl acetate and 616.88 g of acetyl chloride and 543 g of ethanol were added.Stir crystallization at room temperature for 6 h. Filtration, get dapoxetine hydrochloride.Dried in vacuo to give 2.42 kg of a white powdery solid. Yield: 90.1%, purity (HPLC): 99.92%, chiral purity: 99.81%. Ethyl acetate recovery cycle.[0100] The crude 2.4 mg of crude dapoxetine hydrochloride was weighed, 4.8 L of ethanol was added, and the mixture was heated to reflux. After the solution became clear, 14.5 L of methyl t-butyl ether was added and the mixture was stirred overnight at room temperature. Suction filter, get dapoxetine hydrochloride refined products. Dried in vacuo to give 2.34 kg of a white powdery solid. Yield 97.5%, purity (HPLC): 99.997%, chiral purity: 99.89%.
Detailed step in step (3) of the present embodiment is as follows: the reaction flask in three 2000ml 3-dimethylaminopropyl-3-phenyl-propanol (III) 41.23g (0.23mol) was dissolved in 800ml DMF, the ice bath was 5 minutes under stirring added in 118g mass fraction of 25% n-butyllithium solution was stirred for about 30min, was added 40.34g (0.276mol) 1- fluoronaphthalene was slowly heated to 110 deg.] C, and reacted at this temperature for 8h, and then the reaction was cooled to rt, quenched, 200ml × 3 extracted with methylene chloride (15%) the combined organic phases were washed with dilute hydrochloric acid, the organic phase was separated, dried over anhydrous sodium sulfate, filtered, concentrated to dryness, ethyl acetate was added 180ml esters, beating, centrifuged, and dried 50 deg.] C and dried under reduced pressure to give 77.8 g of crude product, a yield of 98.95%.
  • 3
  • [ 81402-52-0 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: ethyl acetate; ethanol / 1 h / 30 °C / Reflux 2.1: caustic lye / dichloromethane; water / 0.5 h / 20 °C / pH 9 - 10 3.1: sodium hydroxide / dimethyl sulfoxide / 4 h / 100 °C 3.3: pH ~ 9 4.1: hydrogenchloride / ethyl acetate; isopropyl alcohol / 0 - 20 °C
Multi-step reaction with 4 steps 1.1: ethanol; acetone / 30 - 58 °C 2.1: caustic lye / dichloromethane; water / 0.17 h / 20 °C 3.1: sodium hydroxide / dimethyl sulfoxide / 4 h / 100 °C 3.3: pH ~ 9 4.1: hydrogenchloride / ethyl acetate; isopropyl alcohol / 0 - 20 °C
Multi-step reaction with 3 steps 1.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 65 °C / Inert atmosphere 1.2: 10 h / 120 °C 1.3: 80 °C 2.1: potassium hydroxide / water / 0.5 h / Cooling with ice 3.1: hydrogenchloride / water; di-isopropyl ether
Multi-step reaction with 4 steps 1.1: sodium hydride / N,N-dimethyl-formamide / 1.5 h / 50 °C / Inert atmosphere 1.2: 6 h / 100 °C 2.1: ethanol; water 3.1: sodium hydroxide / pH >= 13 4.1: hydrogenchloride / acetone
Multi-step reaction with 3 steps 1.1: sodium hydride / N,N-dimethyl-formamide / 1 h / 60 °C / Cooling with ice 1.2: 9 h / 100 °C 2.1: L-Tartaric acid / ethanol; water / 20 °C / Cooling with ice 3.1: hydrogenchloride / water; tert-butyl methyl ether

  • 4
  • [ 1621684-78-3 ]
  • [ CAS Unavailable ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
4.8 kg Stage #1: C20H20O4S; dimethyl amine In tert-butyl methyl ether at 5 - 30℃; for 18h; Large scale reaction; Stage #2: With hydrogenchloride; butanone In tert-butyl methyl ether; water; N,N-dimethyl-formamide at 10 - 15℃; for 1h; optical yield given as %ee;
  • 5
  • [ 908291-72-5 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: pyridinium chlorochromate / dichloromethane / 12 h / 25 - 30 °C 2.1: borane N,N-diethylaniline complex; (S)-Corey-Bakshi-Shibata oxazaborolidine / 1,2-dimethoxyethane; dichloromethane; water / 9 h / 25 - 30 °C / Inert atmosphere 3.1: triethylamine / tert-butyl methyl ether / 6 h / 5 - 10 °C / Large scale reaction 4.1: tert-butyl methyl ether / 18 h / 5 - 30 °C / Large scale reaction 4.2: 1 h / 10 - 15 °C / pH 1.5
Multi-step reaction with 3 steps 1: N,N-dimethyl-formamide; thionyl chloride / dichloromethane / 3 h / 0 - 5 °C 2: triethylamine / water / 30 h / 25 - 30 °C 3: hydrogenchloride / ethyl acetate; isopropyl alcohol / 2 h / 25 - 30 °C
Multi-step reaction with 4 steps 1.1: N,N-dimethyl-formamide; thionyl chloride / dichloromethane / 3 h / 0 - 5 °C 2.1: triethylamine / water / 30 h / 25 - 30 °C 2.2: 2 h / 25 - 30 °C 3.1: sodium hydroxide / dichloromethane; water 4.1: hydrogenchloride / ethyl acetate; isopropyl alcohol / 2 h / 25 - 30 °C
Multi-step reaction with 2 steps 1.1: methanesulfonyl chloride; triethylamine / tetrahydrofuran / 2 h / -5 - 10 °C 1.2: 16 h / 25 °C 2.1: hydrogenchloride / ethyl acetate / -5 - 20 °C / pH 2

  • 6
  • [ 936-59-4 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: borane-N,N-diethylaniline complex; CBS catalyst / 1,2-dimethoxyethane; dichloromethane; lithium hydroxide monohydrate / 12 h / 25 - 30 °C / Inert atmosphere 2.1: sodium hydroxide / lithium hydroxide monohydrate; N,N-dimethyl-formamide; toluene / 2 h / 90 - 95 °C / Large scale reaction 3.1: triethylamine / 2-methoxy-2-methylpropane / 6 h / 5 - 10 °C / Large scale reaction 4.1: 2-methoxy-2-methylpropane / 18 h / 5 - 30 °C / Large scale reaction 4.2: 1 h / 10 - 15 °C / pH 1.5
Multi-step reaction with 4 steps 1.1: borane-N,N-diethylaniline complex; CBS catalyst / 1,2-dimethoxyethane; dichloromethane; lithium hydroxide monohydrate / 9 h / 25 - 30 °C / Inert atmosphere; Large scale reaction 2.1: sodium hydroxide / lithium hydroxide monohydrate; N,N-dimethyl-formamide; toluene / 2 h / 90 - 95 °C / Large scale reaction 3.1: triethylamine / 2-methoxy-2-methylpropane / 6 h / 5 - 10 °C / Large scale reaction 4.1: 2-methoxy-2-methylpropane / 18 h / 5 - 30 °C / Large scale reaction 4.2: 1 h / 10 - 15 °C / pH 1.5
Multi-step reaction with 4 steps 1.1: (+)-diiso-2-ethylapophosphate pinacylboraneheptane / tetrahydrofuran / 6 h / -20 °C 2.1: sodium hydride / N,N-dimethyl-formamide / 1 h / Cooling with ice 2.2: 1 h / Cooling with ice 3.1: triethylamine; 4-dimethylaminopyridine; methanesulfonyl chloride / tetrahydrofuran / 1 h / Inert atmosphere; Cooling with ice 3.2: 48 h / 20 °C / Sealed tube 4.1: hydrogenchloride / ethyl acetate / 1 h / Cooling with ice
Multi-step reaction with 4 steps 1.1: methanol; potassium borohydrate / 2 h / 0 - 15 °C 2.1: sodium hydroxide / N,N-dimethyl-formamide / 8.5 h / 0 - 55 °C 3.1: methanesulfonyl chloride; triethylamine / tetrahydrofuran / 2 h / -5 - 10 °C 3.2: 16 h / 25 °C 4.1: hydrogenchloride / ethyl acetate / -5 - 20 °C / pH 2
Multi-step reaction with 3 steps 1.1: potassium hydroxide / N,N-dimethyl-formamide / 2 h / 0 °C / Inert atmosphere 1.2: 30 h / 50 °C / Inert atmosphere 2.1: (+)-β-chloro diisopinocampheyl borane / tetrahydrofuran / 20 h / 25 °C / Inert atmosphere 3.1: 4-dimethylaminopyridine; methanesulfonyl chloride; triethylamine / tetrahydrofuran / 4 h / 0 °C 3.2: 25 h / 40 °C
Multi-step reaction with 5 steps 1: Cs2CO3 / propan-2-one / 12 h / 20 °C 2: sodium tetrahydridoborate / methanol / 12 h / 20 °C 3: dichloromethane / 0.5 h / 20 °C 4: sodium hydroxide / dichloromethane; lithium hydroxide monohydrate / 1 h / 20 °C / pH 10 5: hydrogenchloride / ethyl acetate / 20 °C

  • 7
  • [ 100306-33-0 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1.1: sodium hydroxide / water; N,N-dimethyl-formamide; toluene / 2 h / 90 - 95 °C / Large scale reaction 2.1: triethylamine / tert-butyl methyl ether / 6 h / 5 - 10 °C / Large scale reaction 3.1: tert-butyl methyl ether / 18 h / 5 - 30 °C / Large scale reaction 3.2: 1 h / 10 - 15 °C / pH 1.5
Multi-step reaction with 3 steps 1.1: sodium hydride / N,N-dimethyl-formamide / 1 h / Cooling with ice 1.2: 1 h / Cooling with ice 2.1: triethylamine; dmap; methanesulfonyl chloride / tetrahydrofuran / 1 h / Inert atmosphere; Cooling with ice 2.2: 48 h / 20 °C / Sealed tube 3.1: hydrogenchloride / ethyl acetate / 1 h / Cooling with ice
Multi-step reaction with 4 steps 1: potassium hydroxide / acetone / 0 °C / Inert atmosphere; Reflux 2: triethylamine / tert-butyl methyl ether / -10 - 20 °C 3: -5 - 20 °C 4: hydrogenchloride / ethyl acetate; water / 0 - 20 °C / pH 1 - 2
  • 9
  • [ 614-19-7 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 6 steps 1.1: sodium tetrahydroborate; iodine / tetrahydrofuran / 18 h / 66 °C 2.1: 8 h / 95 °C 3.1: sodium hydride / N,N-dimethyl-formamide / 1.5 h / 50 °C / Inert atmosphere 3.2: 6 h / 100 °C 4.1: ethanol; water 5.1: sodium hydroxide / pH >= 13 6.1: hydrogenchloride / acetone
Multi-step reaction with 7 steps 1.1: sodium tetrahydroborate; iodine / tetrahydrofuran / 18 h / 66 °C 2.1: triethylamine / dichloromethane / 0.5 h / -5 - 0 °C 2.2: 1 h / 0 °C 3.1: potassium carbonate / acetone / 0.5 h / 70 °C 4.1: acetic acid / 2 h / 120 °C 5.1: ethanol / 20 °C 6.1: sodium hydroxide / water / pH >= 12 7.1: 8 h / 95 °C
Multi-step reaction with 8 steps 1.1: sodium tetrahydroborate; iodine / tetrahydrofuran / 18 h / 66 °C 2.1: triethylamine / dichloromethane / 0.5 h / -5 - 0 °C 2.2: 1 h / 0 °C 3.1: potassium carbonate / acetone / 0.5 h / 70 °C 4.1: acetic acid / 2 h / 120 °C 5.1: ethanol / 20 °C 6.1: sodium hydroxide / water / pH >= 12 7.1: Cooling with ice 8.1: hydrogenchloride / acetone
Multi-step reaction with 5 steps 1.1: sodium tetrahydroborate / tetrahydrofuran / 0.17 h / Cooling with ice 1.2: 7.5 h / 10 - 65 °C 2.1: water / 10 h / 90 °C / Cooling with ice 3.1: sodium hydride / N,N-dimethyl-formamide / 1 h / 60 °C / Cooling with ice 3.2: 9 h / 100 °C 4.1: L-Tartaric acid / ethanol; water / 20 °C / Cooling with ice 5.1: hydrogenchloride / water; tert-butyl methyl ether

  • 10
  • [ 50-00-0 ]
  • [ CAS Unavailable ]
  • [ 147199-40-4 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
4.8 g Stage #1: formaldehyd; formic acid; Didesmethyldapoxetine at 95℃; for 8h; Stage #2: With hydrogenchloride In water 1.3 Preparation of (s) -N, N-dimethyl 4-phenyl-3- (naphthyl-oxo) propylamine (S) -l-phenyl-3- (naphthyl-1-oxo) propylamine(5.0 g, 0.018 mol) was added to a 100 ml three-necked flask,Add 88% formic acid (4.5 g, 0.09mo 1) under ice bath, stir to dissolve,A 36% formaldehyde solution (4.3 g, 0.054 mol) was slowly added dropwise to the ice bath and the reaction was stirred at 95 ° C for 8 h.By thin layer chromatography (developing agent for ethanol: ethyl acetate = 1: 2, triethylamine a drop), the reaction is completed.Cold to room temperature, ice bath slowly drop 20% NaOH solution,At this point the solution from clarification become muddy,Tune ΡΗ ≥ 12,Add water (20ml) diluted,Placed at room temperature for 30 min,Extracted with dichloromethane (50 ml X)Dried over anhydrous sodium sulfate, filtered, the solvent was evaporated under reduced pressure,To a yellowish clear oil (S) -N, N-dimethyl-1-phenyl-3- (naphthyl-1-oxo)4.8 g (HPLC: 99.80%, value greater than 99.9%). The hydrogen spectrum and the carbon spectrum of the product are as follows:
  • 11
  • [ 119356-76-2 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
76% With hydrogenchloride; (1S)-10-camphorsulfonic acid In ethanol; lithium hydroxide monohydrate at 20℃; for 15h; 1-2 Example 2 50g (0.16mol) racemic dapoxetine was dissolved in 500ml water and 15ml 5M hydrochloric acid solution, and heated to dissolve. Add 19 g (0.08 mol) (S)-(+)-camphor-10-sulfonic acid in 200 ml of absolute ethanol solution, cool the solution to room temperature and let it stand for 15 hours to precipitate a precipitate, filter, and wash with cold ethanol. The filter cake was treated with 1mol NaHCO3 and 150ml ethyl acetate, the aqueous layer was extracted with ethyl acetate (3×100ml), the organic layers were combined and washed with saturated brine. Dry with anhydrous magnesium sulfate and evaporate to dryness under reduced pressure to obtain (S)-Dapoxetine oil. The ethyl acetate was dissolved, and the ethyl acetate solution of hydrogen chloride was added to precipitate crystals and dried in vacuum to obtain 20.8 g of (S)-dapoxetine hydrochloride with an optical purity of ≥99.0%ee and a yield of 76%.
Multi-step reaction with 3 steps 1: ethanol; lithium hydroxide monohydrate 2: sodium hydroxide / pH >= 13 3: hydrogenchloride / propan-2-one
Multi-step reaction with 3 steps 1: dichloromethane / 0.5 h / 20 °C 2: sodium hydroxide / dichloromethane; lithium hydroxide monohydrate / 1 h / 20 °C / pH 10 3: hydrogenchloride / ethyl acetate / 20 °C
  • 12
  • [ CAS Unavailable ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 7 steps 1.1: ammonium acetate / ethanol / 8 h / 80 °C 2.1: sodium tetrahydroborate; iodine / tetrahydrofuran / 18 h / 66 °C 3.1: 8 h / 95 °C 4.1: sodium hydride / N,N-dimethyl-formamide / 1.5 h / 50 °C / Inert atmosphere 4.2: 6 h / 100 °C 5.1: ethanol; water 6.1: sodium hydroxide / pH >= 13 7.1: hydrogenchloride / acetone
Multi-step reaction with 8 steps 1.1: ammonium acetate / ethanol / 8 h / 80 °C 2.1: sodium tetrahydroborate; iodine / tetrahydrofuran / 18 h / 66 °C 3.1: triethylamine / dichloromethane / 0.5 h / -5 - 0 °C 3.2: 1 h / 0 °C 4.1: potassium carbonate / acetone / 0.5 h / 70 °C 5.1: acetic acid / 2 h / 120 °C 6.1: ethanol / 20 °C 7.1: sodium hydroxide / water / pH >= 12 8.1: 8 h / 95 °C
Multi-step reaction with 9 steps 1.1: ammonium acetate / ethanol / 8 h / 80 °C 2.1: sodium tetrahydroborate; iodine / tetrahydrofuran / 18 h / 66 °C 3.1: triethylamine / dichloromethane / 0.5 h / -5 - 0 °C 3.2: 1 h / 0 °C 4.1: potassium carbonate / acetone / 0.5 h / 70 °C 5.1: acetic acid / 2 h / 120 °C 6.1: ethanol / 20 °C 7.1: sodium hydroxide / water / pH >= 12 8.1: Cooling with ice 9.1: hydrogenchloride / acetone
Multi-step reaction with 6 steps 1.1: ammonium acetate / ethanol / 6 h / 78 °C 2.1: sodium tetrahydroborate / tetrahydrofuran / 0.17 h / Cooling with ice 2.2: 7.5 h / 10 - 65 °C 3.1: water / 10 h / 90 °C / Cooling with ice 4.1: sodium hydride / N,N-dimethyl-formamide / 1 h / 60 °C / Cooling with ice 4.2: 9 h / 100 °C 5.1: L-Tartaric acid / ethanol; water / 20 °C / Cooling with ice 6.1: hydrogenchloride / water; tert-butyl methyl ether

  • 13
  • [ 1782065-31-9 ]
  • [ CAS Unavailable ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
91.8% Stage #1: (3R)-1-(3-bromo-3-phenylpropoxy)naphthalene; dimethyl amine at 5℃; Stage #2: With hydrogenchloride In ethyl acetate 2; 3 In the reaction system of Example 1, 10 eq of dimethylamine (1.7 g) was added,Reaction temperature 5 ° C.HPLC monitoring reaction to complete.Respectively, by alkaline water,Water, saturated brine washing,Dried over anhydrous sodium sulfate,Filtration was concentrated under reduced pressure to give Compound 3 (0.84 g) in 87% yield.Compound 3 (0.76 g) was dissolved in ethyl acetate,Access to hydrogen chloride gas,To no precipitation,filter,The resulting solid was recrystallized from isopropanol to give compound 4 (0.78 g)Docetaxine hydrochloride, the yield of 91.8%, purity 99.9%, chiral purity 99.9%
  • 14
  • [ 119357-49-2 ]
  • [ CAS Unavailable ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
Stage #1: 1-(3-bromo-3-phenylpropoxy)naphthalene; dimethyl amine at 20℃; Stage #2: With hydrogenchloride In ethyl acetate 5; 6 In the reaction system of Example 1, 10 eq of dimethylamine (1.7 g) was added,Reaction temperature 5 ° C.HPLC monitoring reaction to complete.Respectively, by alkaline water,Water, saturated brine washing,Dried over anhydrous sodium sulfate,Filtration was concentrated under reduced pressure to give Compound 3 (0.84 g) in 87% yield.Compound 3 (0.76 g) was dissolved in ethyl acetate,Access to hydrogen chloride gas,To no precipitation,filter,The resulting solid was recrystallized from isopropanol to give compound 4 (0.78 g)Docetaxine hydrochloride, the yield of 91.8%, purity 99.9%, chiral purity 99.9%
  • 15
  • [ 156453-53-1 ]
  • [ 506-59-2 ]
  • [ 129938-20-1 ]
YieldReaction ConditionsOperation in experiment
93.75% Stage #1: (R)-(-)-3-(1-naphthalenyloxy)-1-phenyl-1-propanol With dmap; methanesulfonyl chloride; triethylamine In tetrahydrofuran at 0℃; for 4h; Stage #2: N,N-dimethylammonium chloride In tetrahydrofuran at 40℃; for 25h; 1.3 3. Preparation of Dapoxetine hydrochloride Weigh 8.012g of (R)-(-)-3-(1-naphthyloxy)-1-phenyl-1-propanol and a 250ml three-necked flask,5.824g of triethylamine was added and 0.347g of 4-dimethylaminopyridine was stirred to dissolve and cool down to 0°C.Slowly add 4.921 g of MsCl in 15 ml of tetrahydrofuran for 4 hours.After adding dimethylamine hydrochloride, it was reacted at 40°C for 25 hours and added to 300 ml of water.The pH is adjusted to 13 with 5 mol/L NaOH solution under stirring, and the layers are then extracted with 300 ml of ethyl acetate.The organic layer was dried over anhydrous sodium sulfate, then filtered and distilled to an oil, and then cooled and crystallized and white crystals slowly precipitated to obtain solid white dapoxetine free base.After the dapaxetine free base was dissolved in isopropanol, the hydrogen chloride solution in isopropanol was slowly added dropwise.A white solid precipitated, which was collected by suction filtration and washed with isopropanol to give 9.264 g of dapoxetine hydrochloride.The yield is 93.75%, the chemical purity is 99.92%, and the optical purity is 99.87%.
  • 16
  • [ 129938-20-1 ]
  • [ 2825577-69-1 ]
YieldReaction ConditionsOperation in experiment
69.8 % With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 20℃; 1-6 (a) Add dapoxetine hydrochloride (10.0g, 29mmol, 1.0eq), DCM (60mL, dichloromethane, 6V) into a one-necked bottle, add 3-chloroperoxybenzoic acid (6.6g, 38mmol, 1.3 eq), react overnight at room temperature; use TLC (thin-layer chromatography, DCM: the volume ratio of methanol is 10:1) to show that the reaction is complete; (b) Pour the reaction solution into saturated NaHCO3 aqueous solution, extract with dichloromethane, dry and concentrate the organic phase; pass through the column for purification (the developing agent for passing through the column is a mixed solvent of DCM and methanol at a volume ratio of 10 to 30:1, The development effect in this scope is similar) obtains 8.7g yellow oil; (c) Dissolve the above-mentioned yellow oil with 15mL EA (ethyl acetate), and add HCl in ethyl acetate solution dropwise under an ice-water bath (that is, HCl is the solute, ethyl acetate is the solvent, and the concentration is 4mol/L), A white solid was precipitated by stirring, filtered and dried to obtain 7.3 g of a white solid (NMR spectrum is shown in Figure 1). The yield was 69.8%, and the HPLC purity was 99.84% (as shown in Figure 2).
Same Skeleton Products
Historical Records